Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Ovarian Neoplasms 17Fallopian Tube Neoplasms 6Neoplasms 4Breast Neoplasms 4Uterine Cervical Neoplasms 3Carcinoma, Renal Cell 3Carcinoma, Ovarian Epithelial 3Sarcoma 2Recurrence 2Pancreatic Neoplasms 2Melanoma 2Carcinoma, Non-Small-Cell Lung 2Uterine Diseases 1Uterine Cervical Diseases 1Thyroid Neoplasms 1Small Cell Lung Carcinoma 1Recurrent Uterine Corpus Sarcoma 1Prostatic Neoplasms 1Hypertension 1Glioblastoma 1Gastrointestinal Neoplasms 1Endometrial Neoplasms 1Colorectal Neoplasms 1

Interventions

Paclitaxel 2Colposcopy 2Carboplatin 2pazopanib 1Watchful Waiting 1Transurethral Resection of Prostate 1Pregnancy Tests 1Mass Screening 1Isotretinoin 1Human Papillomavirus DNA Tests 1Fluorouracil 1Filgrastim 1Educational Status 1Drug Therapy 1Conization 1Biopsy 1Acetic Acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Uterine Cervical Diseases × pazopanib × Gynecologic × Clear all
NCT00561795 2012-03-22

Feasibility Study of Pazopanib in Combination With Chemotherapy in Gynaecological Tumors

GlaxoSmithKline

Phase 2 Completed
12 enrolled 6 charts
Gynecologic

Carcinoma, Ovarian Epithelial, Uterine Cervical Diseases, Neoplasms, Ovarian Neoplasms, Uterine Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡